Study of early aging after chemotherapy in young testicular cancer patients
Part of Cancer, Hormones & metabolism, Kidney & urinary clinical trials.
This study looks at how chemotherapy may affect “early aging” in people who had metastatic testicular cancer before age 50. It includes people who are starting cisplatin-based chemotherapy and a comparison group with earlier-stage disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had testicular cancer that was metastatic (stage II or higher)
- Your cancer treatment included cisplatin-based chemotherapy as first treatment
- You were younger than 50 when the chemotherapy started (or when metastatic disease was diagnosed)
- If you join the comparison group, you had stage I testicular cancer and were younger than 50 at diagnosis
- You can understand the study and give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how “early aging” changes show up during treatment in young adults with cancer. It may help doctors better understand health effects during curative therapy and improve care for people your age.
This study looks at how people should be followed after treatment for testicular cancer (surgery and, for some, chemotherapy). It may help improve follow-up plans while keeping an eye out for cancer coming back.
This study looks at how thinking and memory may change in children and young adults after a new cancer diagnosis, especially around chemotherapy. It may help doctors better understand and track brain-related side effects early.
This study looks at how chemotherapy and immunotherapy affect the body in older adults with colorectal cancer, especially early side effects. It may help researchers understand why some people lose strength and how to better predict and manage treatment toxicity.
This study tests whether a simple questionnaire can help doctors better understand how well older patients can handle chemotherapy. The goal is to make treatment safer and more personalized.
This study looks at young people (40 or younger at diagnosis) with solid tumors in China. It aims to collect real-world information about their treatments and outcomes to find patterns that could help improve care.
Hear when a new Testicular Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.